Multivariate data regression (analysis of maximum likelihood estimates) of EFS (n = 318 NPM1-mutated AML cases)
| Variable . | Pr > χ2 test . | Hazard ratio (95% confidence limits) . |
|---|---|---|
| Age as continuous variable | 0.1697 | 1.010 (0.996-1.025) |
| FLT3: Mutated vs unmutated | 0.0161 | 1.597 (1.091-2.337) |
| Karyotype: aberrant vs normal | 0.1335 | 1.482 (0.886-2.479) |
| MLD: positive vs negative | 0.4084 | 0.827 (0.526-1.298) |
| Variable . | Pr > χ2 test . | Hazard ratio (95% confidence limits) . |
|---|---|---|
| Age as continuous variable | 0.1697 | 1.010 (0.996-1.025) |
| FLT3: Mutated vs unmutated | 0.0161 | 1.597 (1.091-2.337) |
| Karyotype: aberrant vs normal | 0.1335 | 1.482 (0.886-2.479) |
| MLD: positive vs negative | 0.4084 | 0.827 (0.526-1.298) |
EFS indicates event-free survival; AML, acute myeloid leukemia; Pr, probability; and MLD, multilineage dysplasia.